20-Mar-2026
Lifeward Faces Nasdaq Audit Committee Compliance Challenge
TipRanks (Fri, 20-Mar 5:10 PM ET)
Lifeward signals strategic expansion into oral insulin and AI-powered rehab with Oramed partnership
Seeking Alpha News (Wed, 18-Mar 10:43 AM ET)
Lifeward Non-GAAP EPS of -$2.85 misses by $1.77, revenue of $5.08M misses by $2.79M
Seeking Alpha News (Wed, 18-Mar 8:02 AM ET)
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results
Globe Newswire (Wed, 18-Mar 8:00 AM ET)
Here are the major earnings before the open Wednesday
Seeking Alpha News (Tue, 17-Mar 6:00 PM ET)
Lifeward Q4 2025 Earnings Preview
Seeking Alpha News (Tue, 17-Mar 3:15 PM ET)
Globe Newswire (Fri, 13-Mar 8:00 AM ET)
Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
Globe Newswire (Wed, 11-Mar 8:00 AM ET)
Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
Globe Newswire (Tue, 10-Mar 4:15 PM ET)
Globe Newswire (Mon, 2-Mar 8:00 AM ET)
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
Lifeward Ltd. - trades on the NASDAQ stock market under the symbol LFWD.
As of March 20, 2026, LFWD stock price declined to $6.74 with 13,136 million shares trading.
LFWD has a beta of 0.44, meaning it tends to be less sensitive to market movements. LFWD has a correlation of 0.01 to the broad based SPY ETF.
LFWD has a market cap of $10.28 million. This is considered a Sub-Micro Cap stock.
Last quarter Lifeward Ltd. - reported $5 million in Revenue and -$2.85 earnings per share. This fell short of revenue expectation by $-3 million and missed earnings estimates by -$1.87.
LFWD has underperformed the market in the last year with a return of -70.0%, while the SPY ETF gained +16.6%. In the last 3 month period, LFWD fell short of the market, returning -13.6%, while SPY returned -4.4%. However, in the most recent 2 weeks LFWD has outperformed the stock market by returning +12.2%, while SPY returned -3.3%.
LFWD support price is $6.18 and resistance is $7.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFWD shares will trade within this expected range on the day.